PMC:7299399 / 8667-9043
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T83 | 26-29 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T84 | 168-169 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T85 | 194-201 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T86 | 229-231 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T87 | 370-375 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T38 | 77-86 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T39 | 315-320 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T42 | 0-376 | Sentence | denotes | In the past decade, there has been growing interest in novel, broad-spectrum antiviral compounds, which might be less prone to resistance and could be employed against a wide class of different viruses, including new variants.32−34 Importantly, such therapies could be prescribed until more sophisticated, targeted drugs and vaccines are available for each new emerging virus. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32519842-27575283-158465 | 226-228 | 27575283 | denotes | 32 |
| 32519842-26551316-158466 | 229-231 | 26551316 | denotes | 34 |